EUVIMEDEUVIMED entdecken
Crossref

Colorectal cancer cell-derived exosomal miRNA-372-5p induces immune escape from colorectal cancer via PTEN/AKT/NF-κB/PD-L1 pathway

Yulun Wu, Yuhan Xiao, Yongxing Ding, Ruorong Ran, Ke Wei, Shuang Tao, Huilan Mao, Jing Wang, Siyan Pang, Jiwen Shi, Chengle Zhu, Wenrui Wan und 2 weitere

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.113261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Yulun Wu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu medical university, 2600 Donghai Avenue, Bengbu, A…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, MicroRNAs, PTEN Phosphohydrolase, B7-H1 Antigen. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor cells can escape immune surveillance by changing their own escape or expressing abnormal genes and proteins, resulting in unlimited proliferation and invasive growth of cells. These changes are related to microRNAs (miRNAs), which reduce the killing effect of immune cells, devastate the immune response, and interfere with apoptosis through the aberrant expression of relevant miRNAs. In the preliminary phase of this study, miRNAs in clinical plasma exosomes of colorectal cancer patients were differentially analyzed by RNA sequencing technology, and miR-372-5p derived from extracellular vesicles (sEVs) was found to be a key signaling molecule mediating the regulation of macrophages by colorectal cancer (CRC). miRNA-372-5p is upregulated in colorectal cancer patient tissues and serum, as well as colorectal cancer cell lines and their exosomes. Subsequently, we found that macrophages could take up sEV secreted by colorectal cancer cells HCT116, affecting the expression of the immune checkpoint PD-L1, resulting in the generation of a tumor-immunosuppressive microenvironment and suppression of T cell activation in CRC. Gene enrichment mapping and database revealed that miR-372-5p regulates PD-L1 expression in colorectal cancer through the homologous phosphatase-tensin (PTEN)-phosphatidylinositol 3-kinase-protein kinase B (AKT)-nuclear factor-κB (NF-κB) pathway. Further studies confirmed that miRNA-372-5p-treated macrophages co-cultured with T cells affected the regulation of PD-L1 expression through the PTEN/AKT/NF-κB signaling pathway, resulting in decreased CD3+CD8+ T cell activity, decreased cytokine IL-2 and increased IFN-γ. And miRNA-372-5p could down-regulate the expression of PD-L1 in HCT116 through the PTEN/AKT/NF-κB pathway, inhibit tumor cell proliferation and promote apoptosis. Conclusion: Colorectal cancer cell-derived exosome miR-372-5p can be phagocytosed by colorectal cancer and macrophage cells, regulate the expression of PD-L1 in colorectal cancer cells and macrophages by targeting the PTEN/AKT/NF-κB pathway, and induce the immunosuppressive microenvironment of CRC to promote CRC development. This suggests that inhibiting the secretion of HCT116-specific sEV-miR-372-5p or targeting PD-L1 in tumor-associated macrophages could be a novel approach for CRC treatment and possibly a sensitizing approach for CRC anti-PD-L1 therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsMicroRNAsPTEN PhosphohydrolaseB7-H1 AntigenExosomesNF-kappa BTumor EscapeProto-Oncogene Proteins c-aktSignal TransductionHumansAnimalsMacrophagesGene Expression Regulation, NeoplasticHCT116 CellsMiceTumor MicroenvironmentMaleCell Line, Tumor

Stichwörter der Autor:innen

Colorectal cancerExosomeTumour microenvironmentmiRNAs

Substanzen

MicroRNAsPTEN PhosphohydrolaseB7-H1 AntigenNF-kappa BProto-Oncogene Proteins c-aktCD274 protein, humanPTEN protein, human

Autor:innen und Institutionen

  • Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu medical university, 2600 Donghai Avenue, Bengbu, Anhui 233030, China; Department of Life Sciences, Bengbu Medical Univer…
  • Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu medical university, 2600 Donghai Avenue, Bengbu, Anhui 233030, China; School of Laboratory Medicine, Bengbu Medical Univ…
  • The Third the Pople's Hospital of Bengbu, Anhui 233000, China. Electronic address: dyx0105@163.com.
  • Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu medical university, 2600 Donghai Avenue, Bengbu, Anhui 233030, China. Electronic address: 1760120985@163.com.
  • Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu medical university, 2600 Donghai Avenue, Bengbu, Anhui 233030, China. Electronic address: 1226130768@qq.com.
  • Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu medical university, 2600 Donghai Avenue, Bengbu, Anhui 233030, China. Electronic address: 2011638187@qq.com.

Zitieren

APA

Wu, Y., Xiao, Y., Ding, Y., Ran, R., Wei, K., Tao, S., Mao, H., Wang, J., Pang, S., Shi, J., Zhu, C., Wan, W., Yang, Q., & Chen, C. (2024). Colorectal cancer cell-derived exosomal miRNA-372-5p induces immune escape from colorectal cancer via PTEN/AKT/NF-κB/PD-L1 pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113261

Vancouver

Wu Y, Xiao Y, Ding Y, Ran R, Wei K, Tao S, et al. Colorectal cancer cell-derived exosomal miRNA-372-5p induces immune escape from colorectal cancer via PTEN/AKT/NF-κB/PD-L1 pathway. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113261

BibTeX
@article{Wu2024,
  author = {Wu, Yulun and Xiao, Yuhan and Ding, Yongxing and Ran, Ruorong and Wei, Ke and Tao, Shuang and Mao, Huilan and Wang, Jing and Pang, Siyan and Shi, Jiwen and Zhu, Chengle and Wan, Wenrui and Yang, Qingling and Chen, Changjie},
  title = {Colorectal cancer cell-derived exosomal miRNA-372-5p induces immune escape from colorectal cancer via PTEN/AKT/NF-κB/PD-L1 pathway},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.113261}
}
Kostenlos starten →